Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Short- and long-term impact of vaccination against cytomegalovirus: a modeling study

Fig. 2

Overview of the estimation results. a, b The estimated age-specific prevalence of seronegative persons, seropositive persons with low antibody concentrations, and seropositive persons with high antibody concentrations in females (a) and males (b), respectively. c The age-specific reactivation rates per year for females (black) and males (blue), respectively. The solid lines represent the estimated medians, and the shaded regions correspond to 95% credible intervals obtained from 1000 parameter samples from the posterior distribution. The circles are seroprevalence data [33] indicating the fraction of samples that would be classified as seronegative with the cut-off specified by the supplier of the assay. The circle size gives a measure for the number of samples in 1-year age groups. The number of samples per 1-year age group is approximately 35 (females) and 30 (males). Note that the seroprevalence is estimated with high precision and that credible intervals for the reactivation rates are broad

Back to article page